18.13
price down icon0.28%   -0.05
after-market Handel nachbörslich: 18.13
loading
Schlusskurs vom Vortag:
$18.18
Offen:
$18.18
24-Stunden-Volumen:
633.82K
Relative Volume:
0.89
Marktkapitalisierung:
$1.12B
Einnahmen:
$330.50M
Nettoeinkommen (Verlust:
$145.42M
KGV:
10.99
EPS:
1.65
Netto-Cashflow:
$157.96M
1W Leistung:
+4.62%
1M Leistung:
+1.17%
6M Leistung:
-6.11%
1J Leistung:
+18.96%
1-Tages-Spanne:
Value
$17.89
$18.27
1-Wochen-Bereich:
Value
$17.25
$18.34
52-Wochen-Spanne:
Value
$14.32
$21.28

Innoviva Inc Stock (INVA) Company Profile

Name
Firmenname
Innoviva Inc
Name
Telefon
(650) 238-9600
Name
Adresse
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
2025-02-24
Name
Neueste SEC-Einreichungen
Name
INVA's Discussions on Twitter

Vergleichen Sie INVA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INVA
Innoviva Inc
18.13 1.12B 330.50M 145.42M 157.96M 1.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Innoviva Inc Stock (INVA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Eingeleitet Scotiabank Sector Outperform
2024-06-18 Eingeleitet Cantor Fitzgerald Overweight
2022-07-20 Eingeleitet Goldman Neutral
2017-11-20 Eingeleitet Deutsche Bank Hold

Innoviva Inc Aktie (INVA) Neueste Nachrichten

pulisher
Mar 30, 2025

Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Raised by HighTower Advisors LLC - Defense World

Mar 30, 2025
pulisher
Mar 29, 2025

Can Mixed Fundamentals Have A Negative Impact on Innoviva, Inc. (NASDAQ:INVA) Current Share Price Momentum? - Simply Wall St

Mar 29, 2025
pulisher
Mar 27, 2025

Analyst Projects Strong Growth for GSK-Innoviva Partnered Respiratory Drugs - MSN

Mar 27, 2025
pulisher
Mar 26, 2025

Avantax Advisory Services Inc. Grows Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Innoviva (NASDAQ:INVA) Upgraded to “Buy” at StockNews.com - Defense World

Mar 25, 2025
pulisher
Mar 23, 2025

Charles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 21, 2025
pulisher
Mar 21, 2025

Sarissa Capital Management LP Reduces Stake in Innoviva Inc. - GuruFocus.com

Mar 21, 2025
pulisher
Mar 21, 2025

Innoviva, Inc. (NASDAQ:INVA) Shares Sold by PNC Financial Services Group Inc. - Defense World

Mar 21, 2025
pulisher
Mar 17, 2025

Innoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc. - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

Innoviva (NASDAQ:INVA) Downgraded by StockNews.com to Hold - Defense World

Mar 15, 2025
pulisher
Mar 12, 2025

Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - Longview News-Journal

Mar 12, 2025
pulisher
Mar 12, 2025

Armata Lands Critical $10M Funding to Push Revolutionary Phage Therapy Toward FDA Meeting - Stock Titan

Mar 12, 2025
pulisher
Mar 11, 2025

(INVA) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 11, 2025
pulisher
Mar 10, 2025

Innoviva (NASDAQ:INVA) Research Coverage Started at Scotiabank - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $20,966,989.92 in Stock - Defense World

Mar 09, 2025
pulisher
Mar 09, 2025

Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - Nasdaq

Mar 08, 2025
pulisher
Mar 08, 2025

Innoviva stock sees $28 million sale by Alexander J. Denner - Investing.com Australia

Mar 08, 2025
pulisher
Mar 05, 2025

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - BioSpace

Mar 05, 2025
pulisher
Mar 05, 2025

Innoviva CEO Fireside Chat: What Strategic Updates Await at Barclays Healthcare Conference? - Stock Titan

Mar 05, 2025
pulisher
Mar 04, 2025

Principal Financial Group Inc. Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

Mar 04, 2025
pulisher
Mar 02, 2025

Rhumbline Advisers Has $3.25 Million Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World

Mar 02, 2025
pulisher
Feb 28, 2025

Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lowered by Denali Advisors LLC - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

When the Price of (INVA) Talks, People Listen - news.stocktradersdaily.com

Feb 28, 2025
pulisher
Feb 28, 2025

Innoviva, Inc. to Host Earnings Call - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 27, 2025

Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Innoviva (INVA) to Release Earnings on Thursday - Defense World

Feb 27, 2025
pulisher
Feb 27, 2025

Innoviva: Q4 Earnings Snapshot - Thehour.com

Feb 27, 2025
pulisher
Feb 27, 2025

Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 26, 2025

Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace

Feb 26, 2025
pulisher
Feb 26, 2025

Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2025
pulisher
Feb 26, 2025

Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - MarketScreener

Feb 26, 2025
pulisher
Feb 24, 2025

Hussman Strategic Advisors Inc. Increases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

Allspring Global Investments Holdings LLC Cuts Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World

Feb 23, 2025
pulisher
Feb 23, 2025

Innoviva: Underappreciated Strength In Hospital Therapeutics (NASDAQ:INVA) - Seeking Alpha

Feb 23, 2025
pulisher
Feb 22, 2025

StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World

Feb 22, 2025
pulisher
Feb 21, 2025

Innoviva, Inc. (NASDAQ:INVA) Short Interest Update - MarketBeat

Feb 21, 2025
pulisher
Feb 18, 2025

Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World

Feb 18, 2025
pulisher
Feb 17, 2025

Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

(INVA) Investment Analysis - Stock Traders Daily

Feb 17, 2025
pulisher
Feb 16, 2025

Empowered Funds LLC Acquires 4,895 Shares of Innoviva, Inc. (NASDAQ:INVA) - Armenian Reporter

Feb 16, 2025
pulisher
Feb 13, 2025

Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World

Feb 13, 2025
pulisher
Feb 11, 2025

Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq

Feb 11, 2025
pulisher
Feb 10, 2025

Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat

Feb 10, 2025

Finanzdaten der Innoviva Inc-Aktie (INVA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Kapitalisierung:     |  Volumen (24h):